In an age where 85% of patients seek health info online using social media, clinical research professionals are finding new ways to gather patient feedback. With novel technologies like AI and NLP allowing trial stakeholders to better detect drug safety concerns, we explore how diversifying the analysis of new channels through these technologies will allow organisations to improve patient safety efforts and drug performance. Read now. https://bit.ly/3zkQxy2 #drugsafety #patientsafety #AI #NLP
IQVIA Safety & Regulatory Compliance
Hospitals and Health Care
Danbury and Durham, Connecticut and North Carolina 19,654 followers
End-to-end integrated tech services and analytics solutions for safety, regulatory, quality and commercial compliance
Über uns
IQVIA has a vision that goes beyond simply optimizing individual safety, regulatory, quality, and compliance functions. Using cloud-based technology combined with advanced analytics—including artificial intelligence and machine learning—IQVIA is bringing together global regulatory intelligence, safety data, product quality information and legal/ethical guidance on an integrated platform. For customers, this means: • Improved compliance performance at lower cost across all functions • Visibility across their complete compliance landscape • Faster response times • More predictive planning, throughout the product lifecycle Learn more are: www.iqvia.com/GlobalCompliance
- Website
-
https://www.iqvia.com/GlobalCompliance
External link for IQVIA Safety & Regulatory Compliance
- Industrie
- Hospitals and Health Care
- Größe des Unternehmens
- 10.001+ Mitarbeiter
- Hauptsitz
- Danbury and Durham, Connecticut and North Carolina
- Spezialitäten
- commercial compliance, safety compliance, regulatory compliance, quality compliance, and compliance
Aktualisierungen
-
Are you ready to navigate the complexities of post-approval drug lifecycle management? Discover the strategies for success in our latest white paper, “Effective Strategies for Post-Approval Lifecycle Management and Local Pharmacovigilance,” authored by IQVIA’s experts. Discover how to overcome common regulatory challenges, implement effective regulatory strategies, and leverage partnerships for post-approval success. Gain insights into the role of Local Qualified Persons for Pharmacovigilance (LQPPVs) and how they are integral to maintaining compliance and fostering innovation across global markets. Unlock the full potential of your post-approval processes by reading our comprehensive guide: https://bit.ly/3B06euZ #Pharmacovigilance #RegulatoryAffairs #DrugLifecycleManagement #LQPPV #LCM
-
-
Did you know that a proactive approach to artwork creation in preclinical stages helps avoid common mistakes, maximize drug potential, and bring treatments to market faster? From competitor label analysis and aspirational label claims to TPP guidance and early regulatory engagement, IQVIA’s Rama Mohan Rao Chikkam discusses how drug developers can make more informed labelling decisions. Read his insights in full. https://bit.ly/4dYu20N #drugdevelopment #labeling
-
-
Curious about which companies excel in delivering exceptional value, performance, and quality? Frost & Sullivan's Customer Value Leadership Award celebrates those that go beyond good service to create significant value for their customers. Discover why IQVIA’s SmartSolve® eQMS stands out as a proud recipient— read the press release now: https://bit.ly/3XmLpBl
-
Mark your calendars! Jason Berning, the Associate Business Development Director for Regulatory Technology Solutions at IQVIA, will be speaking at the 6th Annual European Medical Device & Diagnostic Post-market Surveillance & Vigilance Conference. With two insightful presentations lined up, this event is a golden opportunity to discover effective solutions for your most significant challenges. Don’t wait, secure your spot today! https://lnkd.in/eCt7hCBr
-
There's still time to register. Don't miss learning how Medical Information is evolving beyond chatbots: https://lnkd.in/deH6VXVc
Are you leveraging Healthcare-grade AI™ technology to optimize Medical Information? Register now for our upcoming webinar and gain crucial insights into the top challenges for MI departments, effective strategies to overcome them, and best practices for integrating advanced technologies into MI services. Learn from our MI experts, Simon Johns and Louise Molloy: https://bit.ly/3MrAmlw #MI #MedicalInformation #MedicalAffairs #GenAI
-
-
With the introduction of the EU’s AI Act, it’s crucial for QARA departments to guide their companies in adhering to new standards. Everything you need to help you future-proof your QARA practices is here, including an on-demand webinar: https://lnkd.in/e3jbBm8W #QARA
-
If you’re heading to the upcoming RAPS Convergence in California, come along to IQVIA Booth #503 to meet our experts! Discover the latest industry innovations from your flexible, efficient, and tech-enabled regulatory partner. See you there! https://bit.ly/47DRX3z #RegulatoryCompliance
-
-
Are you ready for the upcoming FDA R3 regulatory changes? If you need to stay on track with regulatory authority compliance requirements—from EDQM doses and formulations to WHO MPID mapping—IQVIA offers rapid-response solutions for complete compliance. Discover how we can help your PV organization stay focused on what matters. Contact us now! https://bit.ly/3zb0Ep7
-
-
The life sciences industry is on the cusp of transformative regulatory changes, and while the uncertainty is challenging, the latest developments offer real opportunities for drug developers. In this article, IQVIA’s Keith McDonald considers how 2024’s regulatory shifts are paving the way for innovation and acceleration. Read his insights in full. https://bit.ly/3zhcoGz #regulatory #drugdevelopment
-